tiprankstipranks
Trending News
More News >
Nabriva Therapeutics (NBRVF)
OTHER OTC:NBRVF
US Market

Nabriva Therapeutics (NBRVF) Revenue

Compare
1,017 Followers

Nabriva Therapeutics Revenue

Nabriva Therapeutics had a revenue of 2.57M in the quarter ending Jun 30, 2023, with -66.09%. This bring the company's revenue in the last twelve months to 29.39M, Increased -17.43%. In the fiscal year ending Dec 31, 2022, Nabriva Therapeutics had annual revenue of 35.67M with 31.06% growth.
Revenue (ttm)
29.39M
Revenue Growth
P/S Ratio
<0.01
Revenue/Employee
$914,564
Employees
39
Market Cap
$323.00

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2022
35.67M8.45M+31.06%
Dec 31, 2021
27.22M22.19M+441.40%
Dec 31, 2020
5.03M-2.72M-35.12%
Dec 31, 2019
7.75M1.25M+19.20%
Dec 31, 2018
6.50M+∞%
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis